Comparative epigenomics of human and mouse mammary tumors

Berna Demircan, Lisa M. Dyer, Mallory Gerace, Edward K. Lobenhofer, Keith D. Robertson, Kevin D. Brown

Research output: Contribution to journalArticle

44 Scopus citations

Abstract

Gene silencing by aberrant epigenetic chromatin alteration is a well-recognized event contributing to tumorigenesis. Although genetically engineered tumor-prone mouse models have proven a powerful tool in understanding many aspects of carcinogenesis, to date few studies have focused on epigenetic alterations in mouse tumors. To uncover epigenetically silenced tumor suppressor genes (TSGs) in mouse mammary tumor cells, we conducted initial genome-wide screening by combining the treatment of cultured cells with the DNA demethylating drug 5-aza-2'-deoxycytidine (5-azadC) and the histone deacetylase inhibitor trichostatin A (TSA) with expression microarray. By conducting this initial screen on EMT6 cells and applying protein function and genomic structure criteria to genes identified as upregulated in response to 5-azadC/TSA, we were able to identify two characterized breast cancer TSGs (Timp3 and Rprm) and four putative TSGs (AtplB2, Dusp2, FoxJl and Smpd3) silenced in this line. By testing a panel of 10 mouse mammary tumor lines, we determined that each of these genes is commonly hypermethylated, albeit with varying frequency. Furthermore, by examining a panel of human breast tumor lines and primary tumors we observed that the human orthologs of ATPIB2, FOXJl and SMPD3 are aberrantly hypermethylated in the human disease whereas DUSP2 was not hypermethylated in primary breast tumors. Finally, we examined hypermethylation of several genes targeted for epigenetic silencing in human breast tumors in our panel of 10 mouse mammary tumor lines. We observed that the orthologs of Cdhl, RarB, Gstpl, RassFI genes were hypermethylated, whereas neither Dapkl nor Wifl were aberrantly methylated in this panel of mouse tumor lines. From this study, we conclude that there is significant, but not absolute, overlap in the epigenome of human and mouse mammary tumors.

Original languageEnglish (US)
Pages (from-to)83-97
Number of pages15
JournalGenes Chromosomes and Cancer
Volume48
Issue number1
DOIs
StatePublished - Jan 1 2009

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Comparative epigenomics of human and mouse mammary tumors'. Together they form a unique fingerprint.

  • Cite this

    Demircan, B., Dyer, L. M., Gerace, M., Lobenhofer, E. K., Robertson, K. D., & Brown, K. D. (2009). Comparative epigenomics of human and mouse mammary tumors. Genes Chromosomes and Cancer, 48(1), 83-97. https://doi.org/10.1002/gcc.20620